Dianne Nicol
About
In The Last Decade
Dianne Nicol
163 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 168
- Molecular Biology 750
- Public Health, Environmental and Occupational Health 690
- Physiology 379
- Global and Planetary Change 365
- Genetics 337
Countries citing papers authored by Dianne Nicol
This map shows the geographic impact of Dianne Nicol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dianne Nicol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dianne Nicol more than expected).
Fields of papers citing papers by Dianne Nicol
This network shows the impact of papers produced by Dianne Nicol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dianne Nicol. The network helps show where Dianne Nicol may publish in the future.
Co-authorship network of co-authors of Dianne Nicol
This figure shows the co-authorship network connecting the top 25 collaborators of Dianne Nicol. A scholar is included among the top collaborators of Dianne Nicol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dianne Nicol. Dianne Nicol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | The path to reducing duplication of human research ethics review in Australia | 1 |
| 6 | Patent law and the march of technology - did the productivity commission get it right? | 0 |
| 7 | Three dimensions of patent infringement: liability for creation and distribtion of CAD files | 1 |
| 8 | Survival outcomes for men with castrate-resistant prostate cancer (CRPC) treated with a dendritic-cell based vaccine in a randomized controlled trial | 3 |
| 9 | Stem cells and regenerative medicine: From research to clinical applications | 1 |
| 10 | Compulsory Licensing of Patents | 2 |
| 11 | Are the Courts Solving the Emerging Challenges of Biotech Patents? | 0 |
| 12 | 2 | |
| 13 | Biobanks Information Paper 2010 | 18 |
| 14 | Submission to the OECD on the Draft Guidelines for Human Biobanks and Genetic Research Databases | 7 |
| 15 | Cooperative Strategies for Facilitating Use of Patented Inventions in Biotechnology | 6 |
| 16 | Australian Medical Biotechnology: Navigating a Complex Patent Landscape | 2 |
| 17 | Human Cloning and Stem Cell Research | 3 |
| 18 | The Australian Medical Biotechnology Industry and Access to Intellectual Property: Issues for Patent Law Development | 10 |
| 19 | Should Human Genes be Patentable Inventions under Australian Patent Law? | 1 |
| 20 | Current Research: Project on the Legal and Ethical Aspects of Genetic Research in Australia | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.